NCT05478031

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Due to the event of repeated elevated transaminase levels in one subject - elevated ALT/AST up to 6x ULN in the absence of any other potential underlying cause - we have decided to terminate the study.